Advertisement
Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to nurture early research from academic institutions into novel therapeutics.
LAB eN is a unique engagement model that combines Evotec's multimodality drug discovery and pre-clinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial expertise.
LAB eN will focus on addressing unmet need in cardiometabolic diseases as well as rare blood and rare endocrine disorders.
LAB eN has already signed on four academic institutions to participate: Harvard University, Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center.
read more
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook
Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews
|
8 dias atrás
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply
Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews
|
324 dias atrás
Novo Nordisk Says FLOW Trial Achieves Primary Endpoint
Novo Nordisk A/S (NVO) announced Tuesday the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy.
RTTNews
|
436 dias atrás
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%
Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
RTTNews
|
793 dias atrás
Sensex, Nifty Close On Buoyant Note
Despite a sharp setback early on in the session and a subsequent volatile spell during which the market climbed higher but faltered again, the Indian stock market closed on a firm note on Thursday.
Recent soft inflation data from Indian and the U.S., and the progress in U.S.-China trade talks contributed significantly to market's rise.
RTTNews
|
36 minutos atrás
Weak Sentiment In Asian Markets
Sentiment in Asian markets remains subdued as markets digested the latest actions on the trade tariff front.
RTTNews
|
36 minutos atrás
Commodity Currencies Slide, Yen Rises Amid Cautious Trade
The commodity currencies such as Australia, the New Zealand and the Canadian dollars weakened against their major currencies in the Asian session on Thursday, as traders remain cautious amid continued uncertainty surrounding U.S. President Donald Trump's trade policies, despite reaching trade deals between the U.S. and China as well as the U.S. and the U.K.
RTTNews
|
3 h 8 min atrás
Canadian Dollar Drops Against Majors
The Canadian dollar weakened against most major currencies in the Asian session on Thursday.
RTTNews
|
3 h 59 min atrás
